ACADIA Pharmaceuticals Ownership 2024 | Who Owns ACADIA Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

30.82%

Insider Ownership

0.51%

Retail Ownership

68.67%

Institutional Holders

135.00

ACADIA Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP26.01%9.94%42,864,612--792,566,676Mar 31, 2024
RTW INVESTMENTS, LP8.39%3.77%13,829,3152,575,76422.89%255,704,034Mar 31, 2024
VANGUARD GROUP INC8.07%0.00%13,298,541-97,468-0.73%245,890,023Mar 31, 2024
BLACKROCK INC.7.08%0.01%11,668,740258,2572.26%215,755,004Mar 31, 2024
STATE STREET CORP3.64%0.01%6,001,403-463,623-7.17%110,965,941Mar 31, 2024
ECOR1 CAPITAL, LLC3.64%2.80%5,991,479--110,782,447Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.43%0.01%3,999,550-1,178,959-22.77%73,952,000Mar 31, 2024
FMR LLC2.42%0.01%3,993,806-1,271,552-24.15%73,845,466Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.69%0.00%2,793,237101,0853.75%51,654,359Mar 31, 2024
D. E. SHAW & CO., INC.1.60%0.04%2,642,020-1,112,578-29.63%48,850,949Mar 31, 2024
PALO ALTO INVESTORS LP1.47%5.04%2,414,9435,3870.22%44,652,296Mar 31, 2024
FRED ALGER MANAGEMENT, LLC1.37%0.21%2,257,564-919,211-28.94%41,742,358Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.28%0.02%2,105,344340,66619.30%38,927,811Mar 31, 2024
EMERALD ADVISERS, LLC1.00%1.23%1,651,1245,5590.34%30,529,283Mar 31, 2024
FIRST TRUST ADVISORS LP1.00%0.03%1,648,798-128,509-7.23%30,486,275Mar 31, 2024
JUPITER ASSET MANAGEMENT LTD0.97%0.28%1,603,774281,41021.28%29,653,781Mar 31, 2024
MORGAN STANLEY0.89%0.00%1,463,012101,1127.42%27,051,092Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.82%0.09%1,357,97375,7965.91%25,108,921Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.79%0.03%1,307,758-153,474-10.50%23,992,586Mar 31, 2024
EMERALD MUTUAL FUND ADVISERS TRUST0.76%1.20%1,250,229-54,327-4.16%23,116,734Mar 31, 2024

ACADIA Pharmaceuticals's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 26.01% of the company's total share outstanding, currently valued at $792.57M. The top 10 institutional shareholders own together 64.97% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP26.01%9.94%42,864,612--792,566,676Mar 31, 2024
PALO ALTO INVESTORS LP1.47%5.04%2,414,9435,3870.22%44,652,296Mar 31, 2024
CUTTER CAPITAL MANAGEMENT, LP0.40%4.69%658,409327,43698.93%12,173,982Mar 31, 2024
FINEPOINT CAPITAL LP0.51%3.99%840,45370,8009.20%15,539,976Mar 31, 2024
BIRCHVIEW CAPITAL, LP0.15%3.78%250,40010,0004.16%4,629,896Mar 31, 2024
RTW INVESTMENTS, LP8.39%3.77%13,829,3152,575,76422.89%255,704,034Mar 31, 2024
ECOR1 CAPITAL, LLC3.64%2.80%5,991,479--110,782,447Mar 31, 2024
NAN FUNG GROUP HOLDINGS LTD0.06%1.76%102,98473,000243.46%1,904,174Mar 31, 2024
EMERALD ADVISERS, LLC1.00%1.23%1,651,1245,5590.34%30,529,283Mar 31, 2024
EMERALD MUTUAL FUND ADVISERS TRUST0.76%1.20%1,250,229-54,327-4.16%23,116,734Mar 31, 2024
GHOST TREE CAPITAL, LLC0.14%1.15%225,000175,000350.00%4,160,250Mar 31, 2024
GHOST TREE CAPITAL, LLC0.12%1.02%200,000200,000100.00%3,698,000Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC0.31%1.00%518,900404,500353.58%9,594,461Mar 31, 2024
PRIVIUM FUND MANAGEMENT B.V.0.09%0.73%148,400148,400100.00%2,743,916Mar 31, 2024
RICE HALL JAMES & ASSOCIATES, LLC0.40%0.70%664,556-28,296-4.08%12,287,640Mar 31, 2024
CM MANAGEMENT, LLC0.02%0.62%40,00010,00033.33%739,600Mar 31, 2024
ALPHACENTRIC ADVISORS LLC0.03%0.50%45,00019,00073.08%832,050Mar 31, 2024
JGP GLOBAL GESTAO DE RECURSOS LTDA.0.02%0.44%36,7556451.79%679,600Mar 31, 2024
PENN CAPITAL MANAGEMENT COMPANY, LLC0.15%0.41%248,8441,5200.61%4,616,024Mar 31, 2024
ELEQUIN SECURITIES, LLC0.15%0.41%248,844248,844100.00%4,616,024Mar 31, 2024

The largest ACADIA Pharmaceuticals shareholder by % of total assets is BAKER BROS. ADVISORS LP. The company owns 42.86M shares of ACADIA Pharmaceuticals (ACAD), representing 9.94% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RTW INVESTMENTS, LP8.39%3.77%13,829,3152,575,76422.89%255,704,034Mar 31, 2024
SQUAREPOINT OPS LLC0.61%0.03%1,008,983731,931264.19%18,656,096Mar 31, 2024
CANADA PENSION PLAN INVESTMENT BOARD0.40%0.01%661,600661,600100.00%12,232,984Mar 31, 2024
PRUDENTIAL FINANCIAL INC0.65%0.03%1,072,731629,615142.09%19,834,796Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP0.36%0.35%588,500588,500100.00%10,881,365Mar 31, 2024
MARSHALL WACE, LLP0.32%0.01%522,413522,413100.00%9,659,416Mar 31, 2024
CAPITAL FUND MANAGEMENT S.A.0.42%0.04%695,547451,735185.28%12,860,664Mar 31, 2024
CAPTION MANAGEMENT, LLC0.28%0.13%462,200437,2001748.80%8,546,078Mar 31, 2024
CITADEL ADVISORS LLC0.35%0.00%569,258416,224271.98%10,525,581Mar 31, 2024
CANDRIAM S.C.A.0.25%0.05%405,751405,751100.00%7,502,336Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC0.31%1.00%518,900404,500353.58%9,594,461Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.35%0.02%573,800389,800211.85%10,610,000Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.47%0.03%776,700383,87397.72%14,361,183Mar 31, 2024
MACQUARIE GROUP LTD0.28%0.01%467,455379,807433.33%8,643,000Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.39%0.02%644,070363,811129.81%11,908,854Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.22%0.00%357,200357,200100.00%6,604,628Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.28%0.02%2,105,344340,66619.30%38,927,811Mar 31, 2024
CUTTER CAPITAL MANAGEMENT, LP0.40%4.69%658,409327,43698.93%12,173,982Mar 31, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE0.71%0.02%1,171,624325,59638.49%21,663,328Mar 31, 2024
0.19%0.02%312,325312,325100.00%5,621,850Mar 31, 2024

As of Mar 31 2024, ACADIA Pharmaceuticals's largest institutional buyer is RTW INVESTMENTS, LP. The company purchased 2.58M stocks of ACAD, valued at $255.70M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC2.42%0.01%3,993,806-1,271,552-24.15%73,845,466Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.43%0.01%3,999,550-1,178,959-22.77%73,952,000Mar 31, 2024
D. E. SHAW & CO., INC.1.60%0.04%2,642,020-1,112,578-29.63%48,850,949Mar 31, 2024
FRED ALGER MANAGEMENT, LLC1.37%0.21%2,257,564-919,211-28.94%41,742,358Mar 31, 2024
FRONTIER CAPITAL MANAGEMENT CO LLC----823,586-100.00%-Mar 31, 2024
EVENTIDE ASSET MANAGEMENT, LLC----809,391-100.00%-Mar 31, 2024
FULLER & THALER ASSET MANAGEMENT, INC.--73-641,112-99.99%1,352,000Mar 31, 2024
ALYESKA INVESTMENT GROUP, L.P.0.05%0.01%85,696-499,340-85.35%1,584,519Mar 31, 2024
WOODLINE PARTNERS LP----474,159-100.00%-Mar 31, 2024
STATE STREET CORP3.64%0.01%6,001,403-463,623-7.17%110,965,941Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.----300,875-100.00%-Mar 31, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND0.11%0.01%189,272-281,728-59.81%3,499,639Mar 31, 2024
HRT FINANCIAL LP0.02%0.00%34,063-276,499-89.03%629,000Mar 31, 2024
NORDEA INVESTMENT MANAGEMENT AB0.20%0.01%322,504-263,498-44.97%5,937,299Mar 31, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.0.29%0.37%470,338-260,579-35.65%8,696,550Mar 31, 2024
BANK OF AMERICA CORP /DE/0.15%0.00%248,620-259,067-51.03%4,596,985,000Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.07%0.00%109,429-239,299-68.62%2,023,342Mar 31, 2024
BARCLAYS PLC0.08%0.00%131,844-214,959-61.98%2,438,000Mar 31, 2024
WALLEYE CAPITAL LLC0.02%0.00%39,200-203,505-83.85%724,808Mar 31, 2024
SECTOR GAMMA AS----188,111-100.00%-Mar 31, 2024

As of Mar 31 2024, ACADIA Pharmaceuticals's biggest institutional seller is FMR LLC. The company sold -1.27M shares of ACAD, valued at $73.85M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CANADA PENSION PLAN INVESTMENT BOARD0.40%0.01%661,600661,600100.00%12,232,984Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP0.36%0.35%588,500588,500100.00%10,881,365Mar 31, 2024
CANDRIAM S.C.A.0.25%0.05%405,751405,751100.00%7,502,336Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.22%0.00%357,200357,200100.00%6,604,628Mar 31, 2024
0.19%0.02%312,325312,325100.00%5,621,850Mar 31, 2024
WCM INVESTMENT MANAGEMENT, LLC0.17%0.01%282,035282,035100.00%5,214,827Mar 31, 2024
ELEQUIN SECURITIES, LLC0.15%0.41%248,844248,844100.00%4,616,024Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.14%0.02%225,000225,000100.00%4,160,250Mar 31, 2024
GHOST TREE CAPITAL, LLC0.12%1.02%200,000200,000100.00%3,698,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.11%0.00%173,500173,500100.00%3,208,015Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.10%0.00%173,103173,103100.00%3,200,674Mar 31, 2024
PRIVIUM FUND MANAGEMENT B.V.0.09%0.73%148,400148,400100.00%2,743,916Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.0.08%0.32%125,000125,000100.00%2,311,250Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.0.06%0.26%100,000100,000100.00%1,849,000Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.05%0.00%90,00090,000100.00%1,664,100Mar 31, 2024
TWIN TREE MANAGEMENT, LP0.05%0.00%81,70081,700100.00%1,510,633Mar 31, 2024
0.05%0.05%77,36377,363100.00%1,430,442Mar 31, 2024
TWIN TREE MANAGEMENT, LP0.05%0.00%76,88776,887100.00%1,421,641Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.05%0.01%76,50076,500100.00%1,414,485Mar 31, 2024
CAPTION MANAGEMENT, LLC0.04%0.02%66,60066,600100.00%1,231,434Mar 31, 2024
EISLER CAPITAL (US) LLC0.02%0.02%39,34839,348100.00%727,545Mar 31, 2024
SHERBROOKE PARK ADVISERS LLC0.02%0.13%35,40035,400100.00%654,546Mar 31, 2024
B. METZLER SEEL. SOHN & CO. AG0.02%0.01%31,40531,405100.00%580,678Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.02%0.00%30,00030,000100.00%554,700Mar 31, 2024
WESBANCO BANK INC0.02%0.02%26,80026,800100.00%495,532Mar 31, 2024
SQUAREPOINT OPS LLC0.01%0.00%20,20020,200100.00%373,498Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.01%0.08%16,51816,518100.00%305,418Mar 31, 2024
NEBULA RESEARCH & DEVELOPMENT LLC0.01%0.06%14,47314,473100.00%267,606Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.01%0.00%13,99213,992100.00%259,000Mar 31, 2024
HSBC HOLDINGS PLC0.01%0.00%13,14113,141100.00%242,977Mar 31, 2024
CERITY PARTNERS LLC0.01%0.00%12,99212,992100.00%240,222Mar 31, 2024
CANTOR FITZGERALD, L. P.0.01%0.06%12,86412,864100.00%237,654Mar 31, 2024
BUSEY WEALTH MANAGEMENT0.01%0.01%12,39112,391100.00%229,109Mar 31, 2024
CAPSTONE INVESTMENT ADVISORS, LLC0.01%0.00%11,40311,403100.00%210,841Mar 31, 2024
QUARRY LP0.00%0.02%6,0006,000100.00%110,940Mar 31, 2024
HEADLANDS TECHNOLOGIES LLC0.00%0.01%2,6012,601100.00%48,092Mar 31, 2024
PACER ADVISORS, INC.0.00%0.00%1,8221,822100.00%33,689Mar 31, 2024
BANK OF AMERICA CORP /DE/0.00%-700700100.00%12,943,000Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC0.00%0.00%523523100.00%9,670Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.00%0.00%500500100.00%9,245Mar 31, 2024
RISE ADVISORS, LLC0.00%0.00%469469100.00%8,672Mar 31, 2024
ANFIELD CAPITAL MANAGEMENT, LLC0.00%0.00%177177100.00%3,273Mar 31, 2024
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC.-0.00%5353100.00%979Mar 31, 2024
HUNTINGTON NATIONAL BANK--5050100.00%925Mar 31, 2024
CORNERSTONE PLANNING GROUP LLC-0.00%5050100.00%853Mar 31, 2024
GLOBAL RETIREMENT PARTNERS, LLC--2525100.00%462,000Mar 31, 2024
BOKF, NA--1616100.00%292Mar 31, 2024

ACADIA Pharmaceuticals's largest new institutional shareholder by number of shares is CANADA PENSION PLAN INVESTMENT BOARD, purchased 661.60K shares, valued at $12.23M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRONTIER CAPITAL MANAGEMENT CO LLC----823,586-100.00%-Mar 31, 2024
EVENTIDE ASSET MANAGEMENT, LLC----809,391-100.00%-Mar 31, 2024
WOODLINE PARTNERS LP----474,159-100.00%-Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.----300,875-100.00%-Mar 31, 2024
SECTOR GAMMA AS----188,111-100.00%-Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC----130,000-100.00%-Mar 31, 2024
BRIDGER MANAGEMENT, LLC----117,341-100.00%-Mar 31, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC----105,396-100.00%-Mar 31, 2024
PERCEPTIVE ADVISORS LLC----101,000-100.00%-Mar 31, 2024
TORNO CAPITAL, LLC----86,500-100.00%-Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC----73,500-100.00%-Mar 31, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC----67,342-100.00%-Mar 31, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)----60,514-100.00%-Mar 31, 2024
BARCLAYS PLC----57,000-100.00%-Mar 31, 2024
LIGHTHOUSE INVESTMENT PARTNERS, LLC----46,484-100.00%-Mar 31, 2024
GOLDMAN SACHS GROUP INC----46,100-100.00%-Mar 31, 2024
CAPTRUST FINANCIAL ADVISORS----44,164-100.00%-Mar 31, 2024
PARALLAX VOLATILITY ADVISERS, L.P.----40,000-100.00%-Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP----36,754-100.00%-Mar 31, 2024
WAKEFIELD ASSET MANAGEMENT LLLP----35,390-100.00%-Mar 31, 2024
JACKSON CREEK INVESTMENT ADVISORS LLC----32,432-100.00%-Mar 31, 2024
CITIGROUP INC----27,300-100.00%-Mar 31, 2024
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN----26,380-100.00%-Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP----24,268-100.00%-Mar 31, 2024
PEAK6 INVESTMENTS LLC----22,500-100.00%-Mar 31, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD----18,870-100.00%-Mar 31, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----18,351-100.00%-Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----16,595-100.00%-Mar 31, 2024
ALPHA DNA INVESTMENT MANAGEMENT LLC----16,510-100.00%-Mar 31, 2024
AM INVESTMENT STRATEGIES LLC----16,100-100.00%-Mar 31, 2024
AE WEALTH MANAGEMENT LLC----15,282-100.00%-Mar 31, 2024
SECTORAL ASSET MANAGEMENT INC----15,060-100.00%-Mar 31, 2024
MACH-1 FINANCIAL GROUP, LLC----14,726-100.00%-Mar 31, 2024
PDT PARTNERS, LLC----13,599-100.00%-Mar 31, 2024
XTX TOPCO LTD----12,961-100.00%-Mar 31, 2024
PROFIT INVESTMENT MANAGEMENT, LLC----10,306-100.00%-Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----9,728-100.00%-Mar 31, 2024
XPONANCE, INC.----9,552-100.00%-Mar 31, 2024
AFFINITY INVESTMENT ADVISORS, LLC----9,287-100.00%-Mar 31, 2024
FIRST HAWAIIAN BANK----9,080-100.00%-Mar 31, 2024
WALLEYE CAPITAL LLC----8,500-100.00%-Mar 31, 2024
OLD WELL PARTNERS, LLC----8,208-100.00%-Mar 31, 2024
STATE OF WYOMING----8,033-100.00%-Mar 31, 2024
VIDENT ADVISORY, LLC----7,279-100.00%-Mar 31, 2024
CREATIVE PLANNING----7,243-100.00%-Mar 31, 2024
LSP INVESTMENT ADVISORS, LLC----6,950-100.00%-Mar 31, 2024
LEGATO CAPITAL MANAGEMENT LLC----6,577-100.00%-Mar 31, 2024
ALLIANZ ASSET MANAGEMENT GMBH----6,400-100.00%-Mar 31, 2024
KAPITALO INVESTIMENTOS LTDA----5,796-100.00%-Mar 31, 2024
BI ASSET MANAGEMENT FONDSMAEGLERSELSKAB A/S----3,186-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----2,700-100.00%-Mar 31, 2024
KBC GROUP NV----2,659-100.00%-Mar 31, 2024
JTC EMPLOYER SOLUTIONS TRUSTEE LTD----2,200-100.00%-Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----1,280-100.00%-Mar 31, 2024
ADVISORNET FINANCIAL, INC----740-100.00%-Mar 31, 2024
FIRST HORIZON ADVISORS, INC.----338-100.00%-Mar 31, 2024
MACROVIEW INVESTMENT MANAGEMENT LLC----234-100.00%-Mar 31, 2024
RONALD BLUE TRUST, INC.----155-100.00%-Mar 31, 2024
DAGCO, INC.----131-100.00%-Mar 31, 2024
GLASSMAN WEALTH SERVICES----55-100.00%-Mar 31, 2024
BELL INVESTMENT ADVISORS, INC----30-100.00%-Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC----6-100.00%-Mar 31, 2024

ACADIA Pharmaceuticals's largest sold out institutional shareholder by shares sold is FRONTIER CAPITAL MANAGEMENT CO LLC, sold -0.82M shares, valued at -, as of undefined.

ACADIA Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
SPARROW FUNDS3.77%13,435--Feb 29, 2024
Manager Directed Portfolios2.54%416,349--Jan 31, 2024
Vanguard Montgomery Funds2.17%87,414--Dec 31, 2023
LIBERTY ALL STAR GROWTH FUND INC.1.46%184,66631,10520.26%Dec 31, 2023
Alger ETF Trust1.08%7,6844,124115.84%Dec 31, 2023
ALGER FUNDS0.75%723,361-279,021-27.84%Jan 31, 2024
ALGER FUNDS II0.58%130,575-51,384-28.24%Jan 31, 2024
VIRTUS ALTERNATIVE SOLUTIONS TRUST0.51%2,003--Jan 31, 2024
HARTFORD HLS SERIES FUND II INC0.50%123,920--Dec 31, 2023
COLUMBIA ACORN TRUST0.40%1,379,852--Dec 31, 2023
WANGER ADVISORS TRUST0.31%195,101--Dec 31, 2023
T. Rowe Price Quantitative Management Funds, Inc.0.28%1,006,405--Dec 31, 2023
T. Rowe Price Health Sciences Fund, Inc.0.24%1,195,370-106,305-8.17%Dec 31, 2023
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.24%221,386--Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.23%43,38619,24279.70%Dec 29, 2023
PRUDENTIAL SECTOR FUNDS, INC.0.20%426,562--Feb 29, 2024
TEKLA HEALTHCARE INVESTORS0.19%220,013--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.18%86,965--Dec 31, 2023
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.0.17%91,200--Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED FUND0.16%1,702,627232,62915.83%Dec 31, 2023
TEKLA LIFE SCIENCES INVESTORS0.13%72,225--Dec 31, 2023
T. Rowe Price New Horizons Fund, Inc.0.11%1,705,113-5,450-0.32%Dec 31, 2023
Tema ETF Trust0.11%5,0605,060-Feb 29, 2024
ALGER INSTITUTIONAL FUNDS0.10%25,245--Jan 31, 2024
TOCQUEVILLE TRUST0.09%13,000--Jan 31, 2024
FIDELITY MT VERNON STREET TRUST0.08%2,407,888-360,953-13.04%Feb 29, 2024
DELAWARE GROUP EQUITY FUNDS IV0.08%87,648-72,352-45.22%Dec 29, 2023
Voya VARIABLE PRODUCTS TRUST0.08%23,561-431-1.80%Dec 31, 2023
M FUND INC0.08%35,116--Mar 31, 2024
T. Rowe Price Small-Cap Value Fund, Inc.0.08%559,800--Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.07%614,700--Jan 31, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.07%246,715--Dec 31, 2023
T. Rowe Price Mid-Cap Value Fund, Inc.0.06%547,400--Dec 31, 2023
PRUDENTIAL JENNISON BLEND FUND, INC.0.06%38,322--Feb 29, 2024
NEUBERGER BERMAN ADVISERS MANAGEMENT TRUST0.06%98,300--Mar 31, 2024
Voya EQUITY TRUST0.06%87,3105,5176.75%Feb 29, 2024
VANGUARD QUANTITATIVE FUNDS0.06%495,800225,30083.29%Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.06%217,346158,545269.63%Jan 31, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.05%130,565--Dec 31, 2023
Humankind Benefit Corp0.05%1,21127028.69%Dec 31, 2023
BUFFALO FUNDS0.05%108,935--Dec 31, 2023
REYNOLDS FUNDS INC0.04%500--Mar 31, 2024
BlackRock Health Sciences Trust II0.04%115,400--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.04%18,5894652.57%Dec 31, 2023
VANGUARD HORIZON FUNDS0.04%835,323-19,188-2.25%Dec 31, 2023
VANGUARD EXPLORER FUND0.04%476,487-152,692-24.27%Jan 31, 2024
NEUBERGER BERMAN EQUITY FUNDS0.04%372,500--Feb 29, 2024
Federated Hermes MDT Series0.04%89,495-11,110-11.04%Jan 31, 2024
EntrepreneurShares Series Trust0.04%9,686--Dec 31, 2023
T. Rowe Price Equity Series, Inc.0.03%56,628-3,400-5.66%Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.03%220,65115,1617.38%Dec 31, 2023
Gabelli Healthcare & WellnessRx Trust0.03%4,000--Dec 29, 2023
T. Rowe Price Mid-Cap Growth Fund, Inc.0.03%400,000--Dec 31, 2023
AMERICAN CENTURY VARIABLE PORTFOLIOS INC0.03%82,146--Dec 31, 2023
Calvert Responsible Index Series, Inc.0.03%53,364-7,846-12.82%Dec 31, 2023
T. Rowe Price Tax-Efficient Funds, Inc.0.03%3,000--Feb 29, 2024
VANGUARD INDEX FUNDS0.03%12,257,2371,848,78717.76%Dec 31, 2023
BlackRock Health Sciences Trust0.03%10,520--Dec 31, 2023
AMG FUNDS III0.02%3,600--Feb 29, 2024
AMG Funds I0.02%29,3705,19421.48%Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.02%61,3079921.64%Feb 29, 2024
MASTER ADVANTAGE SMID CAP LLC0.02%2,212--Dec 31, 2020
FIDELITY CAPITAL TRUST0.02%174,200--Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.02%3,739--Dec 31, 2023
RBB Fund Trust0.01%14,237-3,500-19.73%Feb 29, 2024
JNL VARIABLE FUND LLC0.01%81,7551,2051.50%Mar 31, 2020
Nushares ETF Trust0.01%90,064--Jan 31, 2024
HUSSMAN INVESTMENT TRUST0.01%42,000--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND III0.01%89,900--Dec 31, 2023
HARBOR FUNDS0.01%229,100--Jan 31, 2024
RYDEX SERIES FUNDS0.01%41,8151,7444.35%Dec 31, 2023
ALPS ETF Trust0.01%120,6885,0344.35%Feb 29, 2024
North Square Investments Trust0.01%91,84020,26028.30%Feb 29, 2024
FINANCIAL INVESTORS TRUST0.01%699,6621,7680.25%Jan 31, 2024
ETFis Series Trust I0.01%11,625-980-7.77%Jan 31, 2024
T. Rowe Price Equity Funds, Inc.0.01%137,238--Dec 31, 2023
WESMARK FUNDS0.01%26,80026,800-Mar 31, 2024
IndexIQ ETF Trust0.01%17,397-1,072-5.80%Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND0.01%124,500--Dec 31, 2023
PFM Multi-Manager Series Trust0.01%4,716--Dec 31, 2023
MSS Series Trust0.01%432--Feb 29, 2024
Principal Exchange-Traded Funds0.01%68,308-13,914-16.92%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.01%1,150,01333,0132.96%Feb 29, 2024
FIDELITY SELECT PORTFOLIOS0.01%350,800--Feb 29, 2024
FIDELITY SECURITIES FUND0.01%492,000--Jan 31, 2024
Calvert Variable Products, Inc.0.01%12,5445044.19%Dec 31, 2023
AMG Funds IV0.01%15,213--Jan 31, 2024
ProFunds0.00%47,25522,24988.97%Jan 31, 2024
RYDEX VARIABLE TRUST0.00%5,7961,41432.27%Dec 31, 2023
INVESCO EXCHANGE-TRADED FUND TRUST0.00%345,12590,37435.48%Jan 31, 2024
GABELLI EQUITY TRUST INC0.00%5,000--Dec 29, 2023
Bernstein Fund Inc0.00%39,910--Dec 31, 2023
ALGER PORTFOLIOS0.00%1,307--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%62,244--Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%637,27521,7873.54%Feb 29, 2024
John Hancock Exchange-Traded Fund Trust0.00%20,509--Jan 31, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.00%2,329--Sep 30, 2023
MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC0.00%1,58832926.13%Sep 30, 2020
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%80,942--Dec 31, 2023
Direxion Shares ETF Trust0.00%410,873146,61355.48%Jan 31, 2024

ACADIA Pharmaceuticals's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 13.44K shares, compromising 3.77% of its total assets.

ACADIA Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24135-53.45%
31 Dec, 2329011.54%
30 Sep, 232608.79%
30 Jun, 23239-0.42%
31 Mar, 232403.00%
31 Dec, 222333.10%
30 Sep, 22226-11.37%
30 Jun, 22255-6.93%
31 Mar, 222744.58%
31 Dec, 212626.50%
30 Sep, 21246-0.81%
30 Jun, 21248-16.22%
31 Mar, 21296-5.43%
31 Dec, 2031311.79%
30 Sep, 20280-9.39%
30 Jun, 2030920.23%
31 Mar, 20257-11.38%
31 Dec, 1929015.54%
30 Sep, 1925121.26%
30 Jun, 19207-2.82%
31 Mar, 192137.58%
31 Dec, 18198-2.46%
30 Sep, 18203-0.49%
30 Jun, 18204-3.32%
31 Mar, 18211-4.95%
31 Dec, 17222-4.31%
30 Sep, 172324.98%
30 Jun, 17221-7.14%
31 Mar, 17238-8.11%
31 Dec, 162590.78%
30 Sep, 162574.90%
30 Jun, 16245-3.92%
31 Mar, 162559.91%
31 Dec, 1523216.00%
30 Sep, 15200-2.91%
30 Jun, 15206-1.90%
31 Mar, 152108.81%
31 Dec, 141937.22%
30 Sep, 141804.05%
30 Jun, 14173-5.98%
31 Mar, 141846.36%
31 Dec, 131738.13%
30 Sep, 1316013.48%
30 Jun, 13141261.54%
31 Mar, 133921.88%
31 Dec, 123288.24%
30 Sep, 1217-19.05%
30 Jun, 1221-4.55%
31 Mar, 122257.14%
31 Dec, 1114-
30 Sep, 1114-
30 Jun, 111416.67%
31 Mar, 111250.00%
31 Dec, 108-11.11%
30 Sep, 109-35.71%
30 Jun, 10147.69%
31 Mar, 10138.33%
31 Dec, 09129.09%
30 Sep, 0911-15.38%
30 Jun, 0913-13.33%
31 Mar, 0915-16.67%
31 Dec, 0818-10.00%
30 Sep, 082042.86%
30 Jun, 0814-6.67%
31 Mar, 0815-11.76%
31 Dec, 07176.25%
30 Sep, 0716-11.11%
30 Jun, 071828.57%
31 Mar, 0714-17.65%
31 Dec, 061721.43%
30 Sep, 061416.67%
30 Jun, 0612-
31 Mar, 061220.00%
31 Dec, 0510100.00%
30 Sep, 055-37.50%
30 Jun, 05860.00%
31 Mar, 05566.67%
31 Dec, 04350.00%
30 Sep, 042-
30 Jun, 042-

As of 31 Mar 24, 135 institutions are holding ACADIA Pharmaceuticals's shares, representing a decrease of -53.45% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2450,788,644-68.05%
31 Dec, 23158,958,8372.95%
30 Sep, 23154,398,726-2.01%
30 Jun, 23157,564,2751.22%
31 Mar, 23155,667,3090.05%
31 Dec, 22155,596,0122.36%
30 Sep, 22152,003,6770.95%
30 Jun, 22150,569,8992.57%
31 Mar, 22146,795,558-0.57%
31 Dec, 21147,636,3542.23%
30 Sep, 21144,409,759-1.98%
30 Jun, 21147,333,2611.61%
31 Mar, 21145,005,093-1.75%
31 Dec, 20147,582,543-1.37%
30 Sep, 20149,637,260-1.77%
30 Jun, 20152,333,435-0.87%
31 Mar, 20153,669,2473.16%
31 Dec, 19148,962,4752.02%
30 Sep, 19146,008,8615.86%
30 Jun, 19137,920,2950.10%
31 Mar, 19137,780,861-1.21%
31 Dec, 18139,469,70216.22%
30 Sep, 18120,001,9092.66%
30 Jun, 18116,893,106-4.12%
31 Mar, 18121,921,4881.96%
31 Dec, 17119,580,9101.94%
30 Sep, 17117,303,487-1.86%
30 Jun, 17119,522,8700.44%
31 Mar, 17118,999,821-1.49%
31 Dec, 16120,799,2682.75%
30 Sep, 16117,564,9586.34%
30 Jun, 16110,558,2710.16%
31 Mar, 16110,382,54913.78%
31 Dec, 1597,011,222-9.76%
30 Sep, 15107,503,09210.03%
30 Jun, 1597,703,5570.84%
31 Mar, 1596,889,5151.73%
31 Dec, 1495,245,0641.76%
30 Sep, 1493,600,770-0.75%
30 Jun, 1494,304,7214.40%
31 Mar, 1490,329,43812.29%
31 Dec, 1380,446,4692.29%
30 Sep, 1378,644,942-3.76%
30 Jun, 1381,714,536110.70%
31 Mar, 1338,781,9353.82%
31 Dec, 1237,353,433486.47%
30 Sep, 126,369,159-30.36%
30 Jun, 129,145,710-6.83%
31 Mar, 129,816,4874.71%
31 Dec, 119,375,139-6.10%
30 Sep, 119,983,970-18.71%
30 Jun, 1112,281,63453.53%
31 Mar, 117,999,58331.41%
31 Dec, 106,087,573-7.22%
30 Sep, 106,561,479-9.50%
30 Jun, 107,250,2701.49%
31 Mar, 107,143,7476.22%
31 Dec, 096,725,3652.46%
30 Sep, 096,563,615-40.49%
30 Jun, 0911,029,030-26.63%
31 Mar, 0915,031,606-14.97%
31 Dec, 0817,677,44638.57%
30 Sep, 0812,756,85131.56%
30 Jun, 089,696,77716.83%
31 Mar, 088,299,911-38.78%
31 Dec, 0713,558,4017.54%
30 Sep, 0712,607,528-11.98%
30 Jun, 0714,323,835143.49%
31 Mar, 075,882,675-33.43%
31 Dec, 068,837,225-4.88%
30 Sep, 069,290,90427.37%
30 Jun, 067,294,428159.38%
31 Mar, 062,812,301-11.97%
31 Dec, 053,194,82251.00%
30 Sep, 052,115,8227.85%
30 Jun, 051,961,83575.26%
31 Mar, 051,119,371-42.55%
31 Dec, 041,948,29410.50%
30 Sep, 041,763,1092.15%
30 Jun, 041,726,000-

ACADIA Pharmaceuticals (ACAD) has 50.79M shares outstanding as of 31 Mar 24, down -68.05% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2430.82%0.33%
31 Dec, 2396.79%1.08%
30 Sep, 2394.46%1.00%
30 Jun, 2397.10%1.06%
31 Mar, 2395.94%1.04%
31 Dec, 2296.24%1.09%
30 Sep, 2293.92%1.08%
30 Jun, 2293.14%1.12%
31 Mar, 2291.05%1.08%
31 Dec, 2191.78%1.14%
30 Sep, 2189.88%1.07%
30 Jun, 2191.84%1.12%
31 Mar, 2190.62%1.03%
31 Dec, 2093.80%1.05%
30 Sep, 2094.63%1.00%
30 Jun, 2097.32%0.99%
31 Mar, 2098.91%1.06%
31 Dec, 1996.42%0.96%
30 Sep, 19100.07%1.10%
30 Jun, 1995.57%1.04%
31 Mar, 1995.69%0.85%
31 Dec, 18105.96%1.15%
30 Sep, 1895.99%1.10%
30 Jun, 1893.58%0.98%
31 Mar, 1897.75%1.05%
31 Dec, 1796.35%1.05%
30 Sep, 1795.77%1.00%
30 Jun, 1797.87%1.02%
31 Mar, 1797.82%0.90%
31 Dec, 16104.26%1.04%
30 Sep, 16100.06%1.05%
30 Jun, 1697.57%0.99%
31 Mar, 1699.13%1.07%
31 Dec, 1596.40%0.85%
30 Sep, 15106.70%1.13%
30 Jun, 1597.36%1.04%
31 Mar, 1596.70%1.06%
31 Dec, 1495.39%1.08%
30 Sep, 1494.07%1.04%
30 Jun, 1495.21%1.01%
31 Mar, 1497.16%1.30%
31 Dec, 1386.53%1.12%
30 Sep, 1387.87%0.92%
30 Jun, 1397.97%4.04%
31 Mar, 1349.25%1.07%
31 Dec, 1267.77%48.56%
30 Sep, 1211.81%3.96%
30 Jun, 1217.27%5.02%
31 Mar, 1218.56%5.75%
31 Dec, 1117.97%5.02%
30 Sep, 1118.91%3.48%
30 Jun, 1123.32%9.24%
31 Mar, 1115.88%10.87%
31 Dec, 1012.09%4.14%
30 Sep, 1017.09%4.78%
30 Jun, 1018.91%5.44%
31 Mar, 1018.64%6.05%
31 Dec, 0917.54%5.69%
30 Sep, 0917.56%2.00%
30 Jun, 0929.63%1.81%
31 Mar, 0940.43%1.78%
31 Dec, 0847.63%4.04%
30 Sep, 0834.35%5.03%
30 Jun, 0826.14%5.21%
31 Mar, 0822.40%1.51%
31 Dec, 0738.51%3.31%
30 Sep, 0734.12%2.26%
30 Jun, 0738.82%10.11%
31 Mar, 0719.60%1.96%
31 Dec, 0631.65%3.24%
30 Sep, 0631.25%4.54%
30 Jun, 0626.25%19.61%
31 Mar, 0611.57%5.49%
31 Dec, 0514.51%17.66%
30 Sep, 059.06%12.76%
30 Jun, 058.43%21.56%
31 Mar, 056.25%5.28%
31 Dec, 0410.88%11.22%
30 Sep, 049.85%1.42%
30 Jun, 0426.34%-

As of 31 Mar 24, ACADIA Pharmaceuticals is held by 30.82% institutional shareholders, representing a 0.33% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2470-56.25%
31 Dec, 2316022.14%
30 Sep, 2313118.02%
30 Jun, 23111-0.89%
31 Mar, 231126.67%
31 Dec, 221053.96%
30 Sep, 22101-2.88%
30 Jun, 22104-18.11%
31 Mar, 2212714.41%
31 Dec, 211112.78%
30 Sep, 21108-14.29%
30 Jun, 21126-18.71%
31 Mar, 21155-4.91%
31 Dec, 201638.67%
30 Sep, 20150-4.46%
30 Jun, 2015728.69%
31 Mar, 20122-26.95%
31 Dec, 1916724.63%
30 Sep, 1913450.56%
30 Jun, 1989-19.82%
31 Mar, 1911112.12%
31 Dec, 18996.45%
30 Sep, 1893-7.00%
30 Jun, 181009.89%
31 Mar, 1891-24.79%
31 Dec, 1712121.00%
30 Sep, 17100-10.71%
30 Jun, 17112-2.61%
31 Mar, 17115-9.45%
31 Dec, 161277.63%
30 Sep, 16118-4.07%
30 Jun, 16123-9.56%
31 Mar, 1613614.29%
31 Dec, 1511913.33%
30 Sep, 1510515.38%
30 Jun, 1591-12.50%
31 Mar, 1510423.81%
31 Dec, 148416.67%
30 Sep, 1472-6.49%
30 Jun, 1477-21.43%
31 Mar, 149820.99%
31 Dec, 1381-
30 Sep, 1381-26.36%
30 Jun, 13110292.86%
31 Mar, 132816.67%
31 Dec, 1224242.86%
30 Sep, 127-41.67%
30 Jun, 1212-20.00%
31 Mar, 1215150.00%
31 Dec, 116-
30 Sep, 116-
30 Jun, 116-14.29%
31 Mar, 117133.33%
31 Dec, 103-
30 Sep, 103-50.00%
30 Jun, 106-33.33%
31 Mar, 10950.00%
31 Dec, 096-25.00%
30 Sep, 098-11.11%
30 Jun, 09912.50%
31 Mar, 098-20.00%
31 Dec, 0810-23.08%
30 Sep, 081362.50%
30 Jun, 08833.33%
31 Mar, 086-50.00%
31 Dec, 0712100.00%
30 Sep, 076-45.45%
30 Jun, 071110.00%
31 Mar, 0710-28.57%
31 Dec, 061427.27%
30 Sep, 061110.00%
30 Jun, 061066.67%
31 Mar, 066-14.29%
31 Dec, 05775.00%
30 Sep, 054-42.86%
30 Jun, 05775.00%
31 Mar, 054300.00%
31 Dec, 041-50.00%
30 Sep, 042-
30 Jun, 042-

70 institutional shareholders have increased their position in ACAD stock as of 31 Mar 24 compared to 160 in the previous quarter (a -56.25% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2440-45.21%
31 Dec, 23731.39%
30 Sep, 2372-5.26%
30 Jun, 237611.76%
31 Mar, 2368-9.33%
31 Dec, 227511.94%
30 Sep, 2267-23.86%
30 Jun, 228810.00%
31 Mar, 2280-14.89%
31 Dec, 219420.51%
30 Sep, 217813.04%
30 Jun, 2169-14.81%
31 Mar, 2181-15.63%
31 Dec, 209611.63%
30 Sep, 2086-8.51%
30 Jun, 209410.59%
31 Mar, 20858.97%
31 Dec, 197811.43%
30 Sep, 1970-1.41%
30 Jun, 197122.41%
31 Mar, 19583.57%
31 Dec, 1856-1.75%
30 Sep, 1857-3.39%
30 Jun, 1859-15.71%
31 Mar, 187016.67%
31 Dec, 1760-18.92%
30 Sep, 177423.33%
30 Jun, 1760-16.67%
31 Mar, 17725.88%
31 Dec, 1668-15.00%
30 Sep, 16806.67%
30 Jun, 167520.97%
31 Mar, 1662-4.62%
31 Dec, 15656.56%
30 Sep, 1561-12.86%
30 Jun, 157016.67%
31 Mar, 1560-11.76%
31 Dec, 146819.30%
30 Sep, 1457-
30 Jun, 14579.62%
31 Mar, 1452-5.45%
31 Dec, 135527.91%
30 Sep, 1343616.67%
30 Jun, 136-
31 Mar, 136100.00%
31 Dec, 123-25.00%
30 Sep, 124-20.00%
30 Jun, 125150.00%
31 Mar, 122-60.00%
31 Dec, 11525.00%
30 Sep, 114-33.33%
30 Jun, 116200.00%
31 Mar, 112-33.33%
31 Dec, 10350.00%
30 Sep, 102-33.33%
30 Jun, 103200.00%
31 Mar, 101-66.67%
31 Dec, 093-
30 Sep, 09--100.00%
30 Jun, 093-
31 Mar, 093-25.00%
31 Dec, 084-
30 Sep, 08--100.00%
30 Jun, 082-50.00%
31 Mar, 084100.00%
31 Dec, 072-71.43%
30 Sep, 077133.33%
30 Jun, 073200.00%
31 Mar, 071-50.00%
31 Dec, 062100.00%
30 Sep, 061-
30 Jun, 06--100.00%
31 Mar, 065400.00%
31 Dec, 051-
30 Sep, 051-
30 Jun, 051-
31 Mar, 05--
31 Dec, 04--
30 Sep, 04--
30 Jun, 04--

40 institutional shareholders have reduced their position in ACAD stock as of 31 Mar 24 compared to 73 in the previous quarter (a -45.21% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24135-53.45%50,788,644-68.05%30.82%0.33%70-56.25%40-45.21%
31 Dec, 2329011.54%158,958,8372.95%96.79%1.08%16022.14%731.39%
30 Sep, 232608.79%154,398,726-2.01%94.46%1.00%13118.02%72-5.26%
30 Jun, 23239-0.42%157,564,2751.22%97.10%1.06%111-0.89%7611.76%
31 Mar, 232403.00%155,667,3090.05%95.94%1.04%1126.67%68-9.33%
31 Dec, 222333.10%155,596,0122.36%96.24%1.09%1053.96%7511.94%
30 Sep, 22226-11.37%152,003,6770.95%93.92%1.08%101-2.88%67-23.86%
30 Jun, 22255-6.93%150,569,8992.57%93.14%1.12%104-18.11%8810.00%
31 Mar, 222744.58%146,795,558-0.57%91.05%1.08%12714.41%80-14.89%
31 Dec, 212626.50%147,636,3542.23%91.78%1.14%1112.78%9420.51%
30 Sep, 21246-0.81%144,409,759-1.98%89.88%1.07%108-14.29%7813.04%
30 Jun, 21248-16.22%147,333,2611.61%91.84%1.12%126-18.71%69-14.81%
31 Mar, 21296-5.43%145,005,093-1.75%90.62%1.03%155-4.91%81-15.63%
31 Dec, 2031311.79%147,582,543-1.37%93.80%1.05%1638.67%9611.63%
30 Sep, 20280-9.39%149,637,260-1.77%94.63%1.00%150-4.46%86-8.51%
30 Jun, 2030920.23%152,333,435-0.87%97.32%0.99%15728.69%9410.59%
31 Mar, 20257-11.38%153,669,2473.16%98.91%1.06%122-26.95%858.97%
31 Dec, 1929015.54%148,962,4752.02%96.42%0.96%16724.63%7811.43%
30 Sep, 1925121.26%146,008,8615.86%100.07%1.10%13450.56%70-1.41%
30 Jun, 19207-2.82%137,920,2950.10%95.57%1.04%89-19.82%7122.41%
31 Mar, 192137.58%137,780,861-1.21%95.69%0.85%11112.12%583.57%
31 Dec, 18198-2.46%139,469,70216.22%105.96%1.15%996.45%56-1.75%
30 Sep, 18203-0.49%120,001,9092.66%95.99%1.10%93-7.00%57-3.39%
30 Jun, 18204-3.32%116,893,106-4.12%93.58%0.98%1009.89%59-15.71%
31 Mar, 18211-4.95%121,921,4881.96%97.75%1.05%91-24.79%7016.67%
31 Dec, 17222-4.31%119,580,9101.94%96.35%1.05%12121.00%60-18.92%
30 Sep, 172324.98%117,303,487-1.86%95.77%1.00%100-10.71%7423.33%
30 Jun, 17221-7.14%119,522,8700.44%97.87%1.02%112-2.61%60-16.67%
31 Mar, 17238-8.11%118,999,821-1.49%97.82%0.90%115-9.45%725.88%
31 Dec, 162590.78%120,799,2682.75%104.26%1.04%1277.63%68-15.00%
30 Sep, 162574.90%117,564,9586.34%100.06%1.05%118-4.07%806.67%
30 Jun, 16245-3.92%110,558,2710.16%97.57%0.99%123-9.56%7520.97%
31 Mar, 162559.91%110,382,54913.78%99.13%1.07%13614.29%62-4.62%
31 Dec, 1523216.00%97,011,222-9.76%96.40%0.85%11913.33%656.56%
30 Sep, 15200-2.91%107,503,09210.03%106.70%1.13%10515.38%61-12.86%
30 Jun, 15206-1.90%97,703,5570.84%97.36%1.04%91-12.50%7016.67%
31 Mar, 152108.81%96,889,5151.73%96.70%1.06%10423.81%60-11.76%
31 Dec, 141937.22%95,245,0641.76%95.39%1.08%8416.67%6819.30%
30 Sep, 141804.05%93,600,770-0.75%94.07%1.04%72-6.49%57-
30 Jun, 14173-5.98%94,304,7214.40%95.21%1.01%77-21.43%579.62%
31 Mar, 141846.36%90,329,43812.29%97.16%1.30%9820.99%52-5.45%
31 Dec, 131738.13%80,446,4692.29%86.53%1.12%81-5527.91%
30 Sep, 1316013.48%78,644,942-3.76%87.87%0.92%81-26.36%43616.67%
30 Jun, 13141261.54%81,714,536110.70%97.97%4.04%110292.86%6-
31 Mar, 133921.88%38,781,9353.82%49.25%1.07%2816.67%6100.00%
31 Dec, 123288.24%37,353,433486.47%67.77%48.56%24242.86%3-25.00%
30 Sep, 1217-19.05%6,369,159-30.36%11.81%3.96%7-41.67%4-20.00%
30 Jun, 1221-4.55%9,145,710-6.83%17.27%5.02%12-20.00%5150.00%
31 Mar, 122257.14%9,816,4874.71%18.56%5.75%15150.00%2-60.00%
31 Dec, 1114-9,375,139-6.10%17.97%5.02%6-525.00%
30 Sep, 1114-9,983,970-18.71%18.91%3.48%6-4-33.33%
30 Jun, 111416.67%12,281,63453.53%23.32%9.24%6-14.29%6200.00%
31 Mar, 111250.00%7,999,58331.41%15.88%10.87%7133.33%2-33.33%
31 Dec, 108-11.11%6,087,573-7.22%12.09%4.14%3-350.00%
30 Sep, 109-35.71%6,561,479-9.50%17.09%4.78%3-50.00%2-33.33%
30 Jun, 10147.69%7,250,2701.49%18.91%5.44%6-33.33%3200.00%
31 Mar, 10138.33%7,143,7476.22%18.64%6.05%950.00%1-66.67%
31 Dec, 09129.09%6,725,3652.46%17.54%5.69%6-25.00%3-
30 Sep, 0911-15.38%6,563,615-40.49%17.56%2.00%8-11.11%--100.00%
30 Jun, 0913-13.33%11,029,030-26.63%29.63%1.81%912.50%3-
31 Mar, 0915-16.67%15,031,606-14.97%40.43%1.78%8-20.00%3-25.00%
31 Dec, 0818-10.00%17,677,44638.57%47.63%4.04%10-23.08%4-
30 Sep, 082042.86%12,756,85131.56%34.35%5.03%1362.50%--100.00%
30 Jun, 0814-6.67%9,696,77716.83%26.14%5.21%833.33%2-50.00%
31 Mar, 0815-11.76%8,299,911-38.78%22.40%1.51%6-50.00%4100.00%
31 Dec, 07176.25%13,558,4017.54%38.51%3.31%12100.00%2-71.43%
30 Sep, 0716-11.11%12,607,528-11.98%34.12%2.26%6-45.45%7133.33%
30 Jun, 071828.57%14,323,835143.49%38.82%10.11%1110.00%3200.00%
31 Mar, 0714-17.65%5,882,675-33.43%19.60%1.96%10-28.57%1-50.00%
31 Dec, 061721.43%8,837,225-4.88%31.65%3.24%1427.27%2100.00%
30 Sep, 061416.67%9,290,90427.37%31.25%4.54%1110.00%1-
30 Jun, 0612-7,294,428159.38%26.25%19.61%1066.67%--100.00%
31 Mar, 061220.00%2,812,301-11.97%11.57%5.49%6-14.29%5400.00%
31 Dec, 0510100.00%3,194,82251.00%14.51%17.66%775.00%1-
30 Sep, 055-37.50%2,115,8227.85%9.06%12.76%4-42.86%1-
30 Jun, 05860.00%1,961,83575.26%8.43%21.56%775.00%1-
31 Mar, 05566.67%1,119,371-42.55%6.25%5.28%4300.00%--
31 Dec, 04350.00%1,948,29410.50%10.88%11.22%1-50.00%--
30 Sep, 042-1,763,1092.15%9.85%1.42%2---
30 Jun, 042-1,726,000-26.34%-2---

ACADIA Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERS-SaleSell3,503$16.94$59.34K32,053
May 03, 2024Teehan Brendanofficer EVP, COO, HEAD OF COMMERCIALS-SaleSell3,477$16.94$58.90K42,133
May 03, 2024Kihara Jamesofficer PRINCIPAL ACCOUNTING OFFICERS-SaleSell1,326$16.94$22.46K14,370
May 03, 2024DAVIS STEPHENdirector, officer CEOS-SaleSell11,427$16.94$193.57K155,231
Apr 09, 2024DAVIS STEPHENdirector, officer CEOS-SaleSell8,858$17.87$158.29K161,983
Apr 09, 2024DAVIS STEPHENdirector, officer CEOS-SaleSell17,716$17.87$316.58K144,267

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERS-SaleSell3,503$16.94$59.34K32,053
May 03, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERM-ExemptSell6,814--20,445
May 03, 2024Teehan Brendanofficer EVP, COO, HEAD OF COMMERCIALS-SaleSell3,477$16.94$58.90K42,133
May 03, 2024Teehan Brendanofficer EVP, COO, HEAD OF COMMERCIALM-ExemptSell6,814--20,445
May 03, 2024Kihara Jamesofficer PRINCIPAL ACCOUNTING OFFICERS-SaleSell1,326$16.94$22.46K14,370
May 03, 2024Kihara Jamesofficer PRINCIPAL ACCOUNTING OFFICERM-ExemptSell2,596--7,788
May 03, 2024DAVIS STEPHENdirector, officer CEOS-SaleSell11,427$16.94$193.57K155,231
May 03, 2024DAVIS STEPHENdirector, officer CEOM-ExemptSell22,391--67,173
Apr 09, 2024DAVIS STEPHENdirector, officer CEOS-SaleSell8,858$17.87$158.29K161,983
Apr 09, 2024DAVIS STEPHENdirector, officer CEOS-SaleSell17,716$17.87$316.58K144,267
Apr 09, 2024DAVIS STEPHENdirector, officer CEOM-ExemptSell34,666--138,666
Apr 09, 2024DAVIS STEPHENdirector, officer CEOM-ExemptSell17,333--34,667

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERM-ExemptBuy6,814--35,556
May 03, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERS-SaleSell3,503$16.94$59.34K32,053
May 03, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERM-ExemptSell6,814--20,445
May 03, 2024Teehan Brendanofficer EVP, COO, HEAD OF COMMERCIALM-ExemptBuy6,814--45,610
May 03, 2024Teehan Brendanofficer EVP, COO, HEAD OF COMMERCIALS-SaleSell3,477$16.94$58.90K42,133
May 03, 2024Teehan Brendanofficer EVP, COO, HEAD OF COMMERCIALM-ExemptSell6,814--20,445
May 03, 2024Kihara Jamesofficer PRINCIPAL ACCOUNTING OFFICERM-ExemptBuy2,596--15,696
May 03, 2024Kihara Jamesofficer PRINCIPAL ACCOUNTING OFFICERS-SaleSell1,326$16.94$22.46K14,370
May 03, 2024Kihara Jamesofficer PRINCIPAL ACCOUNTING OFFICERM-ExemptSell2,596--7,788
May 03, 2024DAVIS STEPHENdirector, officer CEOM-ExemptBuy22,391--166,658
May 03, 2024DAVIS STEPHENdirector, officer CEOS-SaleSell11,427$16.94$193.57K155,231
May 03, 2024DAVIS STEPHENdirector, officer CEOM-ExemptSell22,391--67,173
Apr 15, 2024Thompson Elizabeth H.Z.-Buy----
Apr 09, 2024DAVIS STEPHENdirector, officer CEOM-ExemptBuy34,666--170,841
Apr 09, 2024DAVIS STEPHENdirector, officer CEOS-SaleSell8,858$17.87$158.29K161,983
Apr 09, 2024DAVIS STEPHENdirector, officer CEOS-SaleSell17,716$17.87$316.58K144,267
Apr 09, 2024DAVIS STEPHENdirector, officer CEOM-ExemptSell34,666--138,666
Apr 09, 2024DAVIS STEPHENdirector, officer CEOM-ExemptBuy17,333--136,175
Apr 09, 2024DAVIS STEPHENdirector, officer CEOM-ExemptSell17,333--34,667
Apr 09, 2024Teehan Brendanofficer EVP, COO, HEAD OF COMMERCIALM-ExemptBuy5,024--41,364

The last insider sell of ACADIA Pharmaceuticals's stock was made by Schneyer Mark C. on May 03 2024, selling 3,503 shares at $16.94 per share (valued at $59.34K).

ACADIA Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024102050.00%
Q1 20241917111.76%
Q4 202391369.23%
Q3 20231616.67%
Q2 20236135174.29%
Q1 2023132065.00%
Q4 20225683.33%
Q3 20221--
Q2 20223412283.33%
Q1 20221615106.67%
Q4 202151631.25%
Q3 20212--
Q2 2021218262.50%
Q1 20213022136.36%
Q4 202051050.00%
Q3 202055100.00%
Q2 2020304075.00%
Q1 20203721850.00%
Q4 2019143243.75%
Q3 201991181.82%

10 total buy trades, and 20 total sell trades (buy/sell ratio of 0.50%) were made by ACADIA Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-10-
Q1 2024-10-
Q4 2023-6-
Q3 2023-5-
Q2 2023141593.33%
Q1 2023-9-
Q4 2022-3-
Q3 2022---
Q2 2022-6-
Q1 2022-10-
Q4 2021-3-
Q3 2021---
Q2 2021-4-
Q1 2021-12-
Q4 2020-5-
Q3 2020-2-
Q2 2020-19-
Q1 20202612600.00%
Q4 2019-18-
Q3 20192450.00%

As of Q2 2024, Insider owners conducted 0 open market buy trades and 10 open market sell trades of ACADIA Pharmaceuticals's stocks.

ACADIA Pharmaceuticals Peer Ownership


TickerCompany
TERNTerns Pharmaceuticals, Inc.
PTCTPTC Therapeutics, Inc.
AKROAkero Therapeutics, Inc.
VKTXViking Therapeutics, Inc.
FBIOFortress Biotech, Inc.
ATHAAthira Pharma, Inc.
RVPHReviva Pharmaceuticals Holdings, Inc.
BPMCBlueprint Medicines Corporation
MDGLMadrigal Pharmaceuticals, Inc.
CABACabaletta Bio, Inc.
SRPTSarepta Therapeutics, Inc.
HEPAHepion Pharmaceuticals, Inc.
KRYSKrystal Biotech, Inc.

ACAD Ownership FAQ


ACADIA Pharmaceuticals is owned by institutional shareholders (30.82%), insiders (0.51%), and public (68.67%). The largest institutional shareholder of ACADIA Pharmaceuticals is BAKER BROS. ADVISORS LP (26.01% of total shares) and the top mutual fund owner is SPARROW FUNDS (3.77% of total shares).

ACADIA Pharmaceuticals's major institutional shareholders are BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, VANGUARD GROUP INC, BLACKROCK INC., and STATE STREET CORP. The top five shareholders own together 53.19% of the company's share outstanding.

As of Mar 2024, there are 135 institutional shareholders of ACADIA Pharmaceuticals.

BAKER BROS. ADVISORS LP owns 42.86M shares of ACADIA Pharmaceuticals, representing 26.01% of the company's total shares outstanding, valued at $792.57M (as of Mar 2024).

As of Mar 2024, RTW INVESTMENTS, LP holds 13.83M shares of ACADIA Pharmaceuticals (ACAD), compromising 8.39% of the company, valued at $255.7M.

VANGUARD GROUP INC is the third largest holder of ACADIA Pharmaceuticals. The company owns 13.3M of the company's shares outstanding (worth $245.89M).